NPCE Similar Chart Price Prediction
The price of NPCE is predicted to go up -14.08%, based on the high correlation periods with CTSO. The similarity of these two price pattern on the periods is 92.58%.
NPCE
CTSO
Down: -14.08%Similarity: 92.58%
NPCE Revenue Forecast
NPCE EPS Forecast
NPCE FAQs
What is revenue forecast for next quarter？
What is eps forecast for next quarter？
NPCE Analyst's Forecast
Priya Sachdeva
UBS
Strong Buy
Price Target
$17
Upside
+30.17%
UBS analyst Priya Sachdeva initiated coverage of NeuroPace with a Buy rating and $17 price target. The firm views NeuroPace's responsive neuromodulation system technology as providing a "differentiated, and clinically proven interventional solution to address the vastly undertreated and underpenetrated" drug resistant epilepsy market. The shares should see multiple expansion over the next twelve months as the company is "on the verge" of addressable market expanding catalysts in the second half of 2025 that should drive a growth inflection, the analyst tells investors in a research note.
Robbie Marcus
JP Morgan
Buy
Price Target
$9 → $14
Upside
+21.53%